Download PDF
Thromb Haemost 2000; 84(04): 735-736
DOI: 10.1055/s-0037-1614103
Letters to the Editor
Schattauer GmbH

Adult Transient Lupus Anticoagulant Patients Maintain an Acquired Activated Protein C Resistance Profile

J. Moore
1   The St. Vincents Hospital, Darlinghurst, NSW, Australia
,
M. Aboud
2   Royal North Shore Hospital, Sydney, NSW, Australia
,
D. Ma
1   The St. Vincents Hospital, Darlinghurst, NSW, Australia
› Author AffiliationsThe authors wish to thank Kim Sheather for data management and Kelly Wong for statistical analysis. This work was supported by an educational grant from the Northern Sydney Area Health Service research grant program, NSW, Australia.
Further Information

Publication History

Received 08 March 2000

Accepted after revision 02 May 2000

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

This work was carried out at Royal North Shore Hospital.


 

  • References

  • 1 Male C, Lechner K, Speiser W, Pabinger I. Transient lupus anticoagulants in children: Stepwise disappearance of diagnostic features. Thromb Haemost 2000; 83: 174-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 de Visser MCH, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 93 1271-6.
    PubMedGoogle Scholar
  • 3 Ehrenforth S, Rodtka KP, Scharrer I. Acquired Activated Protein C-Resi-stance in Patients with Lupus Anticoagulants. Thromb Haemost 1995; 74: 797-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Aboud MR, Ma DDF. A Comparison Between Two Activated Protein C Resistance Methods as Routine Diagnostic Tests for Factor V Leiden Mutation. Br J Haematol 1997; 97: 789-803.
    PubMedGoogle Scholar
  • 5 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the Diagnosis of Lupus Anticoagulants - an Update. Thromb Haemost 1995; 74: 1185-90.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 de Ronde H, Bertina RM. Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation. Blood Coagul Fibrinolysis 1999; 10: 7-17.
    CrossrefPubMedGoogle Scholar
  • 7 Rosing J, Middeldorp S, Curvers J. et al. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 1999; 354: 2036-40.
    CrossrefPubMedGoogle Scholar
  • 8 Zivelin A, Gitel S, Griffin JH. et al. Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood 1999; 94: 895-901.
    CrossrefPubMedGoogle Scholar